Physician profile
Linh Vu
NPI 1730654229
$5,960.09
in general payments reported to CMS, 2019-2025
35 companies · $143 in 2025
The $143 reported for 2025 was less than what a typical Family provider received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $1,322 · 2022: $2,103 · 2023: $987 · 2024: $1,406 · 2025: $143.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,515 · Education: $20.22.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,515.27 |
| Education | $20.22 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $791.77 | 2021-2025 | Rybelsus, Ozempic |
| Bayer Healthcare Pharmaceuticals INC. | $508.09 | 2021-2024 | |
| Astrazeneca Pharmaceuticals LP | $488.24 | 2021-2024 | Airsupra, Farxiga, Breztri |
| Abbvie INC. | $484.81 | 2021-2025 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $444.56 | 2021-2023 | Jardiance |
| Glaxosmithkline, LLC. | $429.71 | 2021-2024 | Trelegy Ellipta, Arexvy |
| Gilead Sciences, INC. | $255.41 | 2021-2022 | |
| Nestle Healthcare Nutrition INC. | $244.62 | 2021-2023 | |
| Abbott Laboratories | $229.53 | 2022-2025 | Assurity, Jot Dx, Freestyle Libre 2 |
| Lilly USA, LLC | $206.35 | 2021-2025 | Mounjaro, Jardiance, Trulicity |
| Amgen INC. | $192.64 | 2021-2024 | Repatha, Otezla |
| Antares Pharma, INC. | $184.30 | 2022-2023 | Xyosted, Tlando, Nocdurna |
| Exact Sciences Corporation | $177.06 | 2023-2025 | Cologuard Collection Kit |
| Astellas Pharma US INC | $161.84 | 2021-2025 | Veozah |
| Amarin Pharma, INC. | $143.56 | 2021-2022 |
Show all 35 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Linh Vu listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.